1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Leukopenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casper, ES; Gordon, C; Gralla, RJ; Kalman, LA; Kris, MG; Woodcock, TM | 1 |
| Korsmeyer, SJ; Luc, PV; Rahman, A; Schein, PS; Smith, FP; Woolley, PV | 1 |
| Benjamin, RS; Bodey, GP; Burgess, MA; Feldman, LD; Feun, LG; Papadopoulos, N; Plager, C; Savaraj, N; Yap, BS | 1 |
3 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Leukopenia
| Article | Year |
|---|---|
Phase I trial of PCNU.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Nitrosourea Compounds; Thrombocytopenia | 1983 |
Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea.
Topics: Anemia; Drug Evaluation; Half-Life; Humans; Kinetics; Leukopenia; Middle Aged; Mustard Compounds; Neoplasms; Nitrosourea Compounds; Protein Binding; Thrombocytopenia | 1981 |
A phase II trial of PCNU in patients with malignant melanoma and central nervous system metastases.
Topics: Brain Neoplasms; Drug Evaluation; Humans; Injections, Intravenous; Leukopenia; Melanoma; Nitrosourea Compounds; Skin Neoplasms; Thrombocytopenia | 1985 |